Legal and ethical issues of newborn screening

被引:8
作者
Dhanda, RK [1 ]
Reilly, PR [1 ]
机构
[1] Interleukin Genet, Bioeth Program, Waltham, MA 02452 USA
来源
PEDIATRIC ANNALS | 2003年 / 32卷 / 08期
关键词
D O I
10.3928/0090-4481-20030801-11
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Newborn screening raises many ethical and legal concerns, from the bioethics issues commonly faced with genetic testing and the practice of informed consent to the classical medical ethics questions that surround resource allocation. This mandatory, state-based healthcare intervention has not met with the resistance that one might have anticipated, yet it is still not integrated into society to its full potential. While there is room for newborn screening programs to improve on the technical, ethical, and legal fronts, this should not discourage policymakers, physicians, scientists, and other stakeholders from learning from the successful aspects of its implementation and applying these lessons to other, related technologies.
引用
收藏
页码:540 / +
页数:6
相关论文
共 18 条
[11]   Genetic screening of newborns [J].
Levy, HL ;
Albers, S .
ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, 2000, 1 :139-177
[12]  
MCEWEN JE, 1994, AM J HUM GENET, V55, P196
[13]  
*PRICW, 2003, NEWB SCREEN PROGR OV
[14]   Survey of national guidelines for the treatment of phenylketonuria [J].
Schweitzer-Krantz, S ;
Burgard, P .
EUROPEAN JOURNAL OF PEDIATRICS, 2000, 159 (Suppl 2) :S70-S73
[15]  
Vijg J, 1999, ELECTROPHORESIS, V20, P1239, DOI 10.1002/(SICI)1522-2683(19990101)20:6<1239::AID-ELPS1239>3.3.CO
[16]  
2-K
[17]  
Westin Alan F., 1967, Privacy and Freedom
[18]  
Wilson J. M. G., 1968, PRINCIPLES PRACTICE, DOI DOI 10.1001/ARCHINTE.1969.00300130131020